Literature DB >> 22249816

CCK, PYY and PP: the control of energy balance.

K Simpson1, J Parker, J Plumer, S Bloom.   

Abstract

The control of food intake consists of neural and hormonal signals between the gut and central nervous system (CNS). Gut hormones such as CCK, PYY and PP signal to important areas in the CNS involved in appetite regulation to terminate a meal. These hormones can act directly via the circulation and activate their respective receptors in the hypothalamus and brainstem. In addition, gut vagal afferents also exist, providing an alternative pathway through which gut hormones can communicate with higher centres through the brainstem. Animal and human studies have demonstrated that peripheral administration of certain gut hormones reduces food intake and leads to weight loss. Gut hormones are therefore potential targets in the development of novel treatments for obesity and analogue therapies are currently under investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249816     DOI: 10.1007/978-3-642-24716-3_9

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  23 in total

Review 1.  Acute exercise and gastric emptying: a meta-analysis and implications for appetite control.

Authors:  Katy M Horner; Matthew M Schubert; Ben Desbrow; Nuala M Byrne; Neil A King
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

2.  Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues.

Authors:  Veronika Mäde; Kathrin Bellmann-Sickert; Anette Kaiser; Jens Meiler; Annette G Beck-Sickinger
Journal:  ChemMedChem       Date:  2014-08-22       Impact factor: 3.466

Review 3.  Acute exercise and hormones related to appetite regulation: a meta-analysis.

Authors:  Matthew M Schubert; Surendran Sabapathy; Michael Leveritt; Ben Desbrow
Journal:  Sports Med       Date:  2014-03       Impact factor: 11.136

Review 4.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

5.  High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice.

Authors:  V Thieme; N Jolly; A N Madsen; K Bellmann-Sickert; T W Schwartz; B Holst; H M Cox; A G Beck-Sickinger
Journal:  Br J Pharmacol       Date:  2016-10-05       Impact factor: 8.739

Review 6.  Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs.

Authors:  H J Dranse; M E M Kelly; B D Hudson
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

Review 7.  The role of gastrointestinal hormones in hepatic lipid metabolism.

Authors:  Jamie Eugene Mells; Frank A Anania
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115

8.  Oxytocin, feeding, and satiety.

Authors:  Nancy Sabatier; Gareth Leng; John Menzies
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-20       Impact factor: 5.555

9.  Decreased expression of the satiety signal receptor CCKAR is responsible for increased growth and body weight during the domestication of chickens.

Authors:  Ian C Dunn; Simone L Meddle; Peter W Wilson; Chloe A Wardle; Andy S Law; Valerie R Bishop; Camilla Hindar; Graeme W Robertson; Dave W Burt; Stephanie J H Ellison; David M Morrice; Paul M Hocking
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

10.  Peptide and lipid modulation of glutamatergic afferent synaptic transmission in the solitary tract nucleus.

Authors:  Michael C Andresen; Jessica A Fawley; Mackenzie E Hofmann
Journal:  Front Neurosci       Date:  2013-01-10       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.